tetano
Editor, Senior Moderator
Neurol Sci
. 2021 Oct 21.
doi: 10.1007/s10072-021-05679-0. Online ahead of print.
A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms
Xuhuan Tang[SUP] 1 [/SUP], Fang Zheng[SUP] 2 3 4 5 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19), the third type of coronavirus pneumonia after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), is spreading widely worldwide now. This pneumonia causes not only respiratory symptoms but also multiple organ dysfunction, including thrombotic diseases such as ischemic stroke. The purpose of this review is to explore whether COVID-19 is a risk factor for ischemic stroke and its related pathophysiological mechanisms. Based on the high thrombosis rate and frequent strokes of COVID-19 patients, combined with related laboratory indicators and pathological results, the discussion is mainly from two aspects: nerve invasion and endothelial dysfunction. SARS-CoV-2 can directly invade the CNS through blood-borne and neuronal retrograde pathways, causing cerebrovascular diseases. In addition, the endothelial dysfunction in COVID-19 is almost certain. Cytokine storm causes thromboinflammation, and downregulation of ACE2 leads to RAS imbalance, which eventually lead to ischemic stroke.
Keywords: COVID-19; Endothelial dysfunction; Ischemic stroke; SARS-CoV-2; Thrombosis.
. 2021 Oct 21.
doi: 10.1007/s10072-021-05679-0. Online ahead of print.
A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms
Xuhuan Tang[SUP] 1 [/SUP], Fang Zheng[SUP] 2 3 4 5 [/SUP]
Affiliations
- PMID: 34671854
- DOI: 10.1007/s10072-021-05679-0
Abstract
Coronavirus disease 2019 (COVID-19), the third type of coronavirus pneumonia after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), is spreading widely worldwide now. This pneumonia causes not only respiratory symptoms but also multiple organ dysfunction, including thrombotic diseases such as ischemic stroke. The purpose of this review is to explore whether COVID-19 is a risk factor for ischemic stroke and its related pathophysiological mechanisms. Based on the high thrombosis rate and frequent strokes of COVID-19 patients, combined with related laboratory indicators and pathological results, the discussion is mainly from two aspects: nerve invasion and endothelial dysfunction. SARS-CoV-2 can directly invade the CNS through blood-borne and neuronal retrograde pathways, causing cerebrovascular diseases. In addition, the endothelial dysfunction in COVID-19 is almost certain. Cytokine storm causes thromboinflammation, and downregulation of ACE2 leads to RAS imbalance, which eventually lead to ischemic stroke.
Keywords: COVID-19; Endothelial dysfunction; Ischemic stroke; SARS-CoV-2; Thrombosis.